On Monday, Beam Therapeutics Inc. ( BEAM ) announced initial safety and efficacy data from its Phase 1/2 trial of BEAM-302, establishing clinical proof-of-concept as a potential treatment for alpha-1 antitrypsin deficiency (AATD) and for in vivo base editing. The initial safety and efficacy data reported are from all nine patients as of February 26, the data cut-off date. Preliminary results from the first...

09:04 AM EDT, 03/10/2025 (MT Newswires) -- Sernova Biotherapeutics (SVA.TO) said Monday that it appointed Pericles Calias as chief development officer and head of research and development. The regenerative medicine company said Calias brings over two decades of global operational experience in drug product development. His deep expertise in leading all aspects of drug product and cell line development is...

09:05 AM EDT, 03/10/2025 (MT Newswires) -- Spin Master ( SNMSF ) on Monday renewed its global master toy licensee agreement with Universal Products & Experiences for DreamWorks Animation's popular preschool brand Gabby's Dollhouse. The company is preparing a new toy line which will launch in the fall, inspired by DreamWorks Animation's upcoming feature film, Gabby's Dollhouse: The Movie. Shares...

09:04 AM EDT, 03/10/2025 (MT Newswires) -- Consumer stocks were flat to lower premarket Monday with the Consumer Staples Select Sector SPDR Fund ( XLP ) down 0.3% and the Consumer Discretionary Select Sector SPDR Fund ( XLY ) recently inactive. Star Entertainment said it is assessing a recapitalization proposal from Bally's (BALY) worth AU$250 million ($158.1 million), which could...